Recent Updates
Recently added Catalysts
NPCE Neutral Sentiment

NeuroPace to Report Third Quarter 2026 Financial Results on November 12, 2026

Key Takeaway: NeuroPace, Inc. will announce its financial results for Q3 2026 on November 12, 2026. The report will be released after market close, followed by a conference call at 1:30 p.m. PT. Investors can access the call to hear management's insights.

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~38 mo
Minimal dilution risk
Lead asset
RNS System
Phase 2 · Epilepsy

Full Press Release Details

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2026 after market close on Thursday, November 12, 2026. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).Investors interested in listening to the conference call may do so by access

Frequently Asked Questions

When will NeuroPace report its Q3 2026 results?

NeuroPace will report its Q3 2026 results on November 12, 2026.

What time is the NeuroPace conference call?

The conference call will begin at 1:30 p.m. Pacific Time.

How can investors access the conference call?

Investors can access the conference call via the company's website.

What is NeuroPace focused on?

NeuroPace focuses on transforming the lives of people living with epilepsy.

Last updated: Oct 29, 2026